BANK VONTOBEL/PUT/MEDTRONIC/75/0.1/20.12.24 Share Price

Warrant

DE000VD8V0K0

Market Closed - Boerse Frankfurt Warrants 11:23:32 08/07/2024 pm IST
0.29 EUR +11.54% Intraday chart for BANK VONTOBEL/PUT/MEDTRONIC/75/0.1/20.12.24
Current month+28.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
08/24/08 0.29 +11.54%
05/24/05 0.26 -10.34%
04/24/04 0.29 +3.57%
03/24/03 0.28 -6.67%
02/24/02 0.3 +11.11%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 11:23 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD8V0K
ISINDE000VD8V0K0
Date issued 27/06/2024
Strike 75 $
Maturity 20/12/2024 (165 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.225
Delta-0.37x
Omega 9.004
Premium6.55x
Gearing24.06x
Moneyness 0.9761
Difference Strike -1.84 $
Difference Strike %-2.45%
Spread 0.01
Spread %3.33%
Theoretical value 0.2950
Implied Volatility 22.16 %
Total Loss Probability 57.61 %
Intrinsic value 0.000000
Present value 0.2950
Break even 71.81 €
Theta-0.01x
Vega0.02x
Rho-0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
76.84 USD
Average target price
94.02 USD
Spread / Average Target
+22.36%
Consensus